Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
A year after the initial outbreak, the COVID-19 pandemic caused by SARS-CoV-2 virus remains a serious threat to global health, while current treatment options are insufficient to bring major improvements. The aim of this study is to identify repurposable drug candidates with a potential to reverse t...
Main Authors: | Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/87 |
Similar Items
-
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
by: Tamizhini Loganathan, et al.
Published: (2020-06-01) -
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019-06-01) -
Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
by: Andrés Pizzorno, et al.
Published: (2019-01-01) -
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01) -
A Rapid Strategy for Repurposing Drugs for COVID-19
by: Maryam Khoubnasabjafari, et al.
Published: (2020-11-01)